Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mitochondria-targeted anti-tumor agents

Mitochondria-targeted anti-tumor agents

US Patent 9987294 · Granted Jun 5, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Variant survivin vaccine for treatment of myeloma2025
Methods of detecting and treating a tumor expressing pT346 PDK12021
Variant survivin vaccine for treatment of myeloma2021
Double mutant survivin vaccine2019
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins2015
Mitochondria-targeted anti-tumor agents2013
Mitochondria-targeted anti-tumor agents2013
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins2013
Detection of survivin in the biological fluids of cancer patients2010
Detection of survivin in the biological fluids of cancer patients2010
Methods for selectively modulating survivin apoptosis pathways2009
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins2008